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In Brief
Swartz et al. find that individual
differences in a readily assayed neural
biomarker, threat-related amygdala
reactivity, predict psychological
vulnerability to common life stressors as
much as 1 to 4 years later.
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We all experience a host of common life stressors
such as the death of a family member, medical
illness, and financial uncertainty. While most of us
are resilient to such stressors, continuing to func-
tion normally, for a subset of individuals, experi-
encing these stressors increases the likelihood of
developing treatment-resistant, chronic psychologi-
cal problems, including depression and anxiety. It
is thus paramount to identify predictive markers of
risk, particularly those reflecting fundamental bio-
logical processes that can be targets for interven-
tion and prevention. Using data from a longitudinal
study of 340 healthy young adults, we demonstrate
that individual differences in threat-related amygdala
reactivity predict psychological vulnerability to life
stress occurring as much as 1 to 4 years later. These
results highlight a readily assayed biomarker, threat-
related amygdala reactivity, which predicts psy-
chological vulnerability to commonly experienced
stressors and represents a discrete target for inter-
vention and prevention.
INTRODUCTION
Exposure to stressful life events is a robust risk factor for
the development of treatment-resistant, chronic psychological
problems including major depression and anxiety disorders
(Faravelli, 1985; Galea et al., 2002; Kendler et al., 1999). How-
ever, whereas most individuals experience stressful life events
at some point, the lifetime prevalence for major depression
and anxiety disorders is 17% and 29%, respectively (Kessler
et al., 2005), indicating that only a subset of individuals expe-
riencing life events will ultimately develop psychopathology.
The ability to prospectively identify which individuals are
at greatest risk represents a critical gap in our ability to effec-
tively intervene and prevent the emergence of disabling
psychological problems. Focusing such efforts on biological
processes involved in stress reactivity and regulation is
particularly important as they represent not only predictive
markers of risk but also discrete targets for intervention and
prevention.Amygdala reactivity to threat is a prime candidate biomarker
for psychological risk to common stressors given its critical roles
in threat detection, stress reactivity, and memory for negative in-
formation (Herman and Cullinan, 1997; Kim et al., 2003; Murty
et al., 2010; Pessoa and Ungerleider, 2004). Thus, relatively
greater amygdala reactivity to common stressors could lead to
an altered stress response and biased appraisal and memory
of stressful events, all of which are core symptoms and features
of depression and anxiety disorders (Burke et al., 2005; Espejo
et al., 2012; Fales et al., 2008; Hamilton and Gotlib, 2008). Not
surprisingly, heightened threat-related amygdala reactivity is
consistently observed in patients with depression and anxiety
(Etkin and Wager, 2007; Groenewold et al., 2013). However,
cross-sectional research in patients cannot determine whether
heightened amygdala reactivity is a premorbid vulnerability
present before the development of symptoms, or whether this
neural phenotype is a secondary correlate that emerges as a
downstream consequence of the onset of symptoms. Prospec-
tive research is required to address this limitation and test
whether amygdala reactivity predicts internalizing symptoms at
a future point in time, controlling for baseline symptom levels.
Adolescents at heightened risk for the development of depres-
sion and anxiety through a positive family history for these disor-
ders evidence heightened amygdala reactivity to threat (Joor-
mann et al., 2012; Monk et al., 2008; Swartz et al., 2014),
suggesting that this neural biomarker can be observed before
the onset of disorder. It remains to be determined, however,
whether such heightened amygdala reactivity predicts the devel-
opment of internalizing symptoms following the experience of
stress in the future. Indeed, only two studies with small samples
have examined such a prospective association, with both finding
that relatively increased amygdala reactivity measured before
the experience of a major traumatic event (i.e., warzone combat
[Admon et al., 2009] or a terrorist attack [McLaughlin et al., 2014])
predicted greater subsequent posttraumatic stress disorder
symptoms. While these findings suggest that threat-related
amygdala reactivity may represent a predictive biomarker of
psychological vulnerability to extreme and rare forms of trauma,
we do not know whether threat-related amygdala reactivity has
similar predictive utility in the broader population, who experi-
ence milder forms of common stressful life events.
To examine whether relatively increased threat-related amyg-
dala reactivity prospectively predicts psychological vulnerability
to common life stressors, we used fMRI to assess baseline
threat-related amygdala reactivity in 753 participants aged 18–
22 years old, all of whom were free of current depression orNeuron 85, 505–511, February 4, 2015 ª2015 Elsevier Inc. 505
anxiety disorders. We chose a sample of young adults as this
developmental stage marks the beginning of a peak period of
risk for the emergence of a number of internalizing disorders,
including major depression, panic disorder, generalized anxiety
disorder, and posttraumatic stress disorder (Kessler et al.,
2005). A widely utilized and well-established face-matching
paradigm was used to robustly elicit threat-related amygdala
reactivity (Nikolova et al., 2014; Prather et al., 2013). At the
time of scanning, participants reported the number of stressful
life events they had experienced in the prior year, as well as
their experience of childhood trauma and their current levels of
depression and anxiety symptoms. We used these baseline
measures as covariates in all analyses to test whether amygdala
reactivity prospectively predicts future psychological problems
as a function of stress above and beyond participants’ reported
symptoms and stress levels at baseline.
After successful completion of the baseline protocol including
fMRI, all participants were subsequently contacted by e-mail
every 3 months and invited to complete a short online assess-
ment of their current mood and experience of stressful life events
since their last assessment. At baseline and each follow-up, par-
ticipants were given a checklist (Clements and Turpin, 1996) of
stressful life events commonly experienced by students (e.g.,
death of a very good friend, major car accident, parent losing a
job) and were asked to indicate which events had occurred since
the last assessment as well as the impact of that event. We
calculated the sum of all impact scores for each event reported;
thus, higher scores can reflect both a greater number of events
as well as more severe events. Symptoms of depression and
anxiety were reported at baseline and each follow-up assess-
ment (Watson et al., 1995).
RESULTS
Amygdala Reactivity to Threat
fMRI results were first examined in SPM8 to ensure that the task
elicited predicted activation in the amygdala (Figure 1A). As ex-
pected, the contrast of fearful and angry faces > shapes was
associated with bilateral amygdala reactivity: left amygdala,
t(810) = 28.7, p < 0.001 FWE-corrected, peak coordinates (x, y,
z): (22, 6, 18), and right amygdala, t(810) = 32.5, p < 0.001
corrected, (28, 4, 20). A mean parameter estimate reflecting
amygdala reactivity as a function of our task (i.e., fearful
and angry facial expressions versus shapes) was extracted for
each participant and entered into regressionmodels inMPlus v7.
Model A: Using Amygdala Reactivity to Predict
Internalizing Symptoms as a Function of Recent Stress
To test our hypothesis that baseline threat-related amygdala
reactivity predicts psychological vulnerability to the subsequent
experience of common life stressors at any point in the future, we
first created a model (Model A; Figure 1B) using the largest
sample of participants that completed an online assessment at
any time post-scanning. For participants that completedmultiple
assessments, we selected data from the most recent assess-
ment available. Follow-up assessments were available from a to-
tal of 340 participants and were collected approximately 1 year
post-scanning (M = 468 days, Min-Max = 90–1,402). Model A506 Neuron 85, 505–511, February 4, 2015 ª2015 Elsevier Inc.was significant (Table S1; p < 0.001), with the interaction be-
tween amygdala reactivity and life stress reported post-scan-
ning predicting the severity of symptoms (B = 2.01, SE = 0.7,
t(339) = 3.08, p = 0.002). Specifically, individuals with rela-
tively heightened amygdala reactivity at baseline who also re-
ported experiencing greater life stress subsequent to scanning
had significantly greater symptoms at follow-up (Figure 1C
and Figure S1). Exploratory whole-brain results are reported in
Table S2.
Model B: Long-Term Predictive Utility of Amygdala
Reactivity
While Model A confirmed our hypothesis that amygdala reac-
tivity represents a predictive biomarker of psychological vulner-
ability to common life stressors, this model included participants
who completed post-scanning assessments in relatively close
proximity to the scan (e.g., 3 months). To determine the long-
term predictive utility of threat-related amygdala reactivity, we
next analyzed data from only those participants who completed
an online assessment at least 1 year post-scanning (Model B;
Figure 2A). For this model, 192 participants were included who
completed their assessment on average 2 years post-baseline
(M = 683 days, Min-Max = 365–1,402). Model B was significant
(Table S3; p < 0.001), with the interaction between amygdala
reactivity and life stress predicting symptom severity following
stress occurring approximately 2 years later (B = 1.75, SE =
0.8, t(191) = 2.33, p = 0.02). Again, participants with relatively
heightened amygdala reactivity at baseline who experienced
relatively high life stress post-scanning reported the greatest
symptoms (Figure 2B and Figure S2).
Model C: Prospective Assessment of Stressful Life
Events
A limitation of our previousmodels is that we used concurrent re-
ports of life stress and internalizing symptoms from the most
recent assessment available. Participants experiencing greater
negative affect at the time of assessment may be biased toward
indicating greater severity of recent life stress. Therefore, we
created a final model (Model C, Figure 3A) in which life stress
was assessed prospective to the reporting of symptoms. To
equate participants in terms of when stressful life events and
symptoms were measured, we obtained symptoms from as-
sessments completed approximately 1 year post-scanning. We
then computed the mean life stress score for all assessments
completed prior to this, yielding a prospective set of variables
including threat-related amygdala reactivity at baseline, life
stress that occurred post-scanning, and symptoms approxi-
mately 1 year post-scanning. Data from 99 participants were
available for this analysis. The moderation Model C was signifi-
cant (Table S3; p < 0.001), indicating a significant interaction be-
tween threat-related amygdala reactivity and subsequent life
stress in predicting internalizing symptoms 1 year later (B =
5.56, SE = 1.9, t(98) = 2.96, p = 0.003). As in our previousmodels,
individuals with relatively heightened amygdala reactivity who
experienced greater life stress post-scanning reported greater
internalizing symptoms 1 year later (Figure 3B and Figure S3).
The interaction between amygdala reactivity and life stress ex-
plained an additional 5% of the variance in symptoms, above
Figure 1. Model A: All Participants Completing a Post-Scanning Assessment
(A) Participants underwent a baseline fMRI scan to measure threat-related amygdala reactivity. The main effect of task (fearful and angry faces > shapes) elicited
bilateral amygdala reactivity (thresholded at p < 0.05 corrected). (B) Participants were invited to complete an online assessment every 3 months post-scanning.
The light gray boxes indicate the baseline scanning assessment and the dark gray boxes indicate online assessments. For Model A, life stress at Time 2 (as
measured by the Life Events Scale for Students) and internalizing symptoms at Time 2 (as measured by the Mood and Anxiety Symptom Questionnaire) were
taken from the most recent assessment completed by each participant, as indicated by the outlined boxes. (C) Depressive and anxiety symptoms at Time 2 are
plotted as a function of the parameter estimates of threat-related amygdala reactivity and life stress post-scanning (groups divided into terciles). Dotted lines
indicate 95%confidence bands. Internalizing symptomswere predicted by a significant interaction between amygdala reactivity and life stress experienced post-
scanning, B = 2.01, SE = 0.7, t(339) = 3.08, p = 0.002. See also Table S1 and Figure S1.and beyond all covariates, including symptoms reported at
baseline.
DISCUSSION
Using data from a large longitudinal study of healthy young
adults, we provide novel evidence for the utility of threat-
related amygdala reactivity—assessed with fMRI—as a predic-
tive biomarker of risk for broad psychological vulnerability to
commonly experienced stressful life events. Our neural riskbiomarker predicted vulnerability consistent with a diathesis-
stress model in both the short and long term as well as indepen-
dently of negative reporting biases. Critically, we did not find a
main effect of amygdala reactivity in predicting future internal-
izing symptoms, indicating that this neural biomarker predicts
greater symptoms only within the context of experiencing rela-
tively high life stress.
Remarkably, amygdala reactivity measured at one time
point significantly predicted internalizing symptoms, above and
beyond baseline symptoms, as much as 1 to 4 years into theNeuron 85, 505–511, February 4, 2015 ª2015 Elsevier Inc. 507
Figure 2. Model B: All Participants Com-
pleting an Assessment at Least 1 Year
Post-Scanning
(A) For Model B, we selected data from all partic-
ipants who completed a follow-up assessment
at least 1 year post-scanning. (B) Internalizing
symptoms at Time 2 as a function of amygdala
reactivity and life stress experienced post-scan-
ning. Internalizing symptoms were predicted by a
significant interaction between amygdala reac-
tivity and life stress experienced post-scanning,
B = 1.75, SE = 0.8, t(191) = 2.33, p = 0.02. See also
Table S3 and Figure S2.future, indicating possible utility of this neural phenotype for pre-
diction of long-term internalizing outcomes. However, it is impor-
tant to note that the interaction between amygdala reactivity and
stress only explained an additional 1%–5% of the variance in
symptoms, with the long-term model (Model B) evidencing the
weakest effect. There are several methodological limitations of
the current study that may have led us to underestimate the
size of this effect. First, participants were not guaranteed pay-
ment for completing follow-up online assessments but entered
into a larger gift card raffle. Thus, missing data may have biased
our results. Second, life stress was assessed through a self-
report checklist rather than through a more objective approach
such as a calendar interview. Third, our non-clinical sample of
undergraduate students was generally low-risk and the associ-
ated range and variability in internalizing symptoms truncated
in comparison to clinical or high-risk samples. We anticipate
that future research addressing these limitations may find larger
effect sizes than those reported in the present study. Neverthe-
less, these results underscore the need to identify additional508 Neuron 85, 505–511, February 4, 2015 ª2015 Elsevier Inc.biomarkers, whether neural or genetic,
that can explain additional variance in
addition to or in interaction with that ac-
counted for by threat-related amygdala
reactivity.
Notably, a range of previously identi-
fied risk factors for depression and
anxiety disorders are all associated with
relatively increased amygdala reactivity
to threat (Bogdan et al., 2012; Swartz
et al., 2014; Nikolova et al., 2014; White
et al., 2012), and our biomarker is consis-
tent with specific pathways of increased
risk, including exaggerated hypothalam-
ic-pituitary-adrenal axis stress respon-
siveness and cognitive biases. Although
our follow-up assessments did not allow
for direct mapping of threat-related
amygdala reactivity onto formal clinical
diagnosis, the increased stress-related
symptoms of depression and anxiety pre-
dicted by amygdala reactivity have been
directly associated with dysfunction (Bre-
demeier et al., 2010; Buckby et al., 2007),
and relatively increased amygdala reac-tivity is consistently observed in patients with clinical depression
and anxiety disorders (Etkin andWager, 2007; Groenewold et al.,
2013). Thus, threat-related amygdala reactivity represents a
predictive neural biomarker through which a range of risk factors
may create a common diathesis for psychological vulnerability to
the experience of common life stressors in the general popula-
tion. As such, relatively increased threat-related amygdala reac-
tivity further represents a discrete biological mechanism that can
be targeted in the development of novel strategies for more
effective prevention of otherwise chronic and treatment-resis-
tant psychiatric disorders. The amygdala, of course, represents
only one node of an extended corticolimbic circuit supporting
emotion processing and stress responsiveness. Other circuit no-
des include the hypothalamus, brainstem, insula, hippocampal
formation, and prefrontal cortex. Future research using para-
digms designed to target these other circuit nodes as well as
their dynamic interactions may further illuminate biological path-
ways through which individual differences in stress responsive-
ness may eventually manifest as disorder.
Figure 3. Model C: Predicting Symptoms
Reported Approximately 1 Year Post-Scan-
ning from Amygdala Reactivity at Baseline
and Life Stress Reported between the Scan-
ning Session and 1 Year Post-Scanning
(A) For Model C, to obtain a prospective
assessment of life stress, we selected depres-
sion and anxiety symptoms from the assess-
ment completed approximately 1 year post-
scanning (range: 365–455 days) and a mean
stress score from all assessments completed
before then. (B) Internalizing symptoms at Time
2 as a function of amygdala reactivity and life
stress experienced post-scanning (groups
created by median split). Internalizing symptoms
were predicted by a significant interaction be-
tween amygdala reactivity and life stress expe-
rienced post-scanning, B = 5.56, SE = 1.9,
t(98) = 2.96, p = 0.003. See also Table S3 and
Figure S3.EXPERIMENTAL PROCEDURES
Participants
Young adult college students were recruited as part of theDukeNeurogenetics
Study. All procedures were approved by the Duke University Medical Center
and participants provided informed consent before participating in the study.
Participants were included in the present sample if they met the following
criteria: (1) free of medical diagnoses of cancer, stroke, diabetes, chronic kid-
ney or liver disease, or lifetime history of psychotic symptoms; (2) no use of
psychotropic, glucocorticoid, or hypolipidemic medication; (3) no conditions
affecting cerebral blood flow and metabolism (e.g., hypertension); and (4)
met quality control criteria for functional MRI scanning. Moreover, due to our
interest in predicting internalizing symptoms post-scanning, we excluded
any participants with a current mood, anxiety, or eating disorder diagnosis
at the time of scanning, based on the electronic Mini International Neuro-
psychiatric Interview (Sheehan et al., 1998). A covariate was included in
all analyses to control for participants with a non-internalizing diagnosis
(e.g., substance abuse) or with a past internalizing diagnosis. A total of 811
participants met inclusion criteria for the imaging data (see Supplemental
Experimental Procedures for quality control criteria), 57 were excluded for
current psychopathology, and 1 participant was missing data, leaving 753
participants (57% female) ranging in age from 18 to 22 available for analyses
(Table 1).Neuron 85, 505–511Measures: Baseline Assessments
fMRI
Participants performed a face-matching task that
has been shown to elicit robust amygdala reac-
tivity across a range of studies and samples,
including the present sample (Nikolova et al.,
2014; Prather et al., 2013). The current paradigm
consisted of four blocks of face matching inter-
leaved with five blocks of a shape-matching
sensorimotor control task. During face-matching
blocks, participants viewed a trio of faces and
selected one of two faces (on bottom) matching
a target face (on top). Each face block contained
one of the following expressions: fearful, angry,
surprised, and neutral. Each trial in the face-
matching blocks lasted for 4 s with a variable
interstimulus interval (ISI) of 2 to 6 s (M = 4 s),
for a total block length of 48 s. In the control
blocks, each of the six shape trios was presented
for 4 s with a fixed ISI of 2 s, for a total block
length of 36 s. Total task time was 390 s. Detailsregarding fMRI acquisition are reported in the Supplemental Experimental
Procedures.
Covariates
Because we were interested in predicting the future development of internal-
izing symptoms, we controlled for internalizing symptoms at baseline using
the Mood and Anxiety Symptoms Questionnaire (MASQ) Short Form (Watson
et al., 1995). Scores across all subscales (general distress/depression, general
distress/anxiety, anxious arousal, and anhedonia) were summed to create a
measure of total internalizing symptoms. Likewise, because we were inter-
ested in the effect of life stress occurring post-scanning, we controlled for
life stress reported at baseline. To assess life stress, we administered the
Life Events Scale for Students (LESS; Clements and Turpin, 1996) to partici-
pants tomeasure the number of life events that occurred in the past 12months.
Participants also rated the impact that the life event had on them on a 1 to 4
scale (4 = severe impact). The impact score for each event reported was
summed to yield a LESS total impact score; higher values indicate both greater
number and severity of life events. Additional covariates are described in the
Supplemental Experimental Procedures.
Measures: Post-Scanning Assessments
Participants were re-contacted post-scanning to complete follow-up
assessments online every 3 months. Successful completers were entered
into a raffle for one $50 Amazon gift card for each round of follow-up, February 4, 2015 ª2015 Elsevier Inc. 509
Table 1. Participant Characteristics
Mean SD Min Max
Baseline (n = 753)
Age 19.6 years 1.2 years 18 years 22 years
Childhood trauma 33.2 7.9 25 75
Stressful life events
Time 1
10.1 8.2 0 66
Internalizing symptoms
Time 1
110.7 25.4 61 230
Time 2 Scores: Model A (n = 340)
Age 20.8 years 1.5 years 18 years 26 years
Stressful life events
Time 2
4.3 5.3 0 34
Internalizing symptoms
Time 2
110.7 26.4 65 214
Days between imaging
and assessment
467.6 326.7 90 1402
Time 2 Scores: Model B (n = 192)
Age 21.4 years 1.4 years 19 years 26 years
Stressful life events
Time 2
5.4 6.2 0 34
Internalizing symptoms
Time 2
111.6 27.2 65 211
Days between imaging
and assessment
683.0 278.6 365 1402
Time 2 Scores: Model C (n = 99)
Age 20.5 years 1.1 years 19 years 23 years
Stressful life events
Time 2
3.3 4.2 0 27.7
Internalizing symptoms
Time 2
109.9 29.2 65 230
Days between imaging
and assessment
397.3 39.2 365 455
Childhood trauma, total of all subscales of the Childhood Trauma Ques-
tionnaire; stressful life events, total impact score for all life events re-
ported on the Life Events Scale for Students; internalizing symptoms, to-
tal of all subscales on the Mood and Anxiety Symptoms Questionnaire;
SD, standard deviation.assessments. The same questions from the LESS were used to assess
stressful life events in the post-scanning questionnaires; however, for these
assessments participants were asked to report whether any life events had
occurred since their last assessment. Participants also completed the
MASQ Short Form during these post-scanning assessments. In accordance
with our first model (Model A), we selected themost recent assessment avail-
able for all participants and obtained the life stress total impact score from
the LESS and total internalizing symptoms from theMASQ at thismost recent
assessment. For Model B, we took a similar approach, except that we limited
this model to those participants who had completed an assessment at least
1 year post-scanning. In accordance with our final model (Model C), we
selected MASQ symptom scores from questionnaires completed approxi-
mately 1 year post-scanning (the inclusion range was set to 365–455 days
post-scanning, to take into account the fact that participants may not have
completed the assessment exactly 365 days post-scanning). We then
computed the mean of the LESS impact score from each assessment
completed before that (Figure 3A). Extra care was taken in quality control
procedures for these assessments, given that they were administered
online. Specifically, individual item responseswere examined for any obvious510 Neuron 85, 505–511, February 4, 2015 ª2015 Elsevier Inc.patterns of false reporting (e.g., a participant indicates a yes for every stress-
ful life event on the LESS). Attrition analyses are reported in the Supplemental
Experimental Procedures.
Analyses
fMRI
fMRI data were processed in SPM8 using the standard pre-processing
stream used in previously published research from the Duke Neurogenetics
Study. Further details on the procedure and quality control criteria are re-
ported in the Supplemental Experimental Procedures. We hypothesized
that results would be specific to threatening facial expressions (fearful
and angry), thus the main contrast analyzed was fearful and angry faces
> shapes. To examine the specificity of effects to negative expressions,
we also ran analyses with parameter estimates for amygdala reactivity to
neutral faces > shapes as a control condition, reported in the Supplemental
Data. To obtain estimates of amygdala reactivity for each condition, we first
identified functional clusters within the amygdala (defined structurally with
the Automated Anatomical Labeling atlas) activated at p < 0.05 family-
wise error (FWE) corrected within the region of interest for each condition
in SPM8. Then, we extracted parameter estimates for the left and right
amygdala for each condition. This procedure has been used in prior pub-
lished research from the Duke Neurogenetics Study (Nikolova et al.,
2012, 2014). Because left and right amygdala reactivity for our contrast
of interest (fearful and angry faces > shapes) was highly correlated (r =
0.78, p < 0.001), we averaged across hemispheres to obtain one mean
parameter estimate of amygdala reactivity and reduce the number of com-
parisons performed.
Moderation Model
Our hypothesis was that the association between amygdala reactivity and
internalizing symptoms would be moderated by the amount of life stress
experienced post-scanning. After parameter estimates of amygdala reac-
tivity were extracted in SPM8, all subsequent analyses to test this proposed
moderation model were performed in MPlus version 7. Thus, for Models A–C,
MASQ total scores from the follow-up assessment were entered as the
dependent variable, and extracted parameter estimates of amygdala reac-
tivity, the total life stress impact score from follow-up, and the interaction
between these were entered as predictors. The following were included as
covariates: age at themost recent assessment, gender, childhood trauma to-
tal scores, LESS total impact scores from the baseline assessment, MASQ
total scores at baseline, the psychopathology covariate, days between scan-
ning and completing the follow-up questionnaire, and (for Model C only) the
number of assessments contributing to the mean LESS total impact score.
Predictors were mean centered. Because symptoms at Time 2 were moder-
ately skewed, MLR estimation was specified to estimate standard errors
robust to non-normality.
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